Takenaka and colleagues evaluated the association of the AST/ALT ratio with overall survival in a cohort of HNSCC patients that included 156 OOSCC patients in the training set and 102 OOSCC patients in a validation set [17]. The gene discussed is GPT; the disease is head and neck squamous cell carcinoma.